Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07196956 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Electromagnetic Field Therapy on Balance and Gait in Paraparetic Patients

Study acronym: EMT-BG
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 5, 2026 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date: Sep 21, 2025 to Jan 11, 2026
    • Primary completion date: Oct 30, 2025 to Feb 28, 2026
    • Study completion date: Nov 30, 2025 to Mar 1, 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will investigate whether adding electromagnetic field therapy (EMT) to a standard physical therapy program is more effective than physical therapy alone for improving balance and walking ability in paraparetic patients. Thirty patients with paraparesis (weakness in the lower limbs) due to spinal cord lesions between levels T6 and T12 will be randomly assigned to one of two groups. Both groups will receive a 45-minute physical therapy session, three times per week for two months. The physical therapy program will include stretching, strengthening, balance, and gait training exercises. The key difference will be that one group (Group II) will also receive active low-frequency (0.5 Hz) electromagnetic therapy applied to their spine during their sessions, while the other group (Group I) will receive a placebo (inactive) EMT device. Patients will be assessed before and after the 2-month treatment period. The assessments will measure muscle spasticity (using the Modified Ashworth Scale), balance (using the Biodex Balance System), and detailed gait parameters like step length, stride length, and base of support (using a 3D motion analysis system
Trial Details
NCT Number NCT07196956
Lead Sponsor MTI University
Conditions
(from sponsor)		 Paraparesis, Gait Disorders, Neurologic, Postural Balance Disorders
Related terms Gait Disorders, Neurologic, Muscle Spasticity, Paraparesis
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov